ras-transformed NIH 3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude mice.
We previously reported that ras-transformed NIH 3T3 cells could be selected in vivo for increased metastatic ability after intravenous injection into chick embryos, and that the metastatic cell populations expressed increased levels of ras p21 protein. We have tested the metastatic ability of a series of these cells in nude mice, to determine if their properties in the chick embryo experimental metastasis assay predict their metastatic behavior in nude mice. We report here that cells selected for metastatic ability in the chick embryo are also metastatic when assayed in nude mice. We also asked whether the selected cells uniformly expressed higher levels of p21, using an immunocytochemical procedure. We found that p21 expression among individual cells in these populations was quite heterogeneous. There was a direct relationship between the proportions of p21-expressing cells and metastatic ability in both assays, with increased proportions of p21-expressing cells in cell lines selected for metastatic ability. Our results suggest that (a) the experimental (i.v.) metastasis assay in the chick embryo offers an efficient and cost-effective procedure for the identification and selection of cells that are also experimentally metastatic in nude mice, and (b) the metastatic properties of ras-transformed NIH 3T3 cells are due to individual cells that express increased amounts of p21.
London Regional Cancer Centre, Ont., Canada.
A F
AF
Chambers
G H
GH
Denhardt
S M
SM
Wilson
D000818:Animals; D002461:Cell Line, Transformed; D002642:Chick Embryo; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000378:metabolism*; D016283:Proto-Oncogene Proteins p21(ras)
D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras)